These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3108371)
1. Early effects of HIV on CD4 lymphocytes in vivo. Giorgi JV; Fahey JL; Smith DC; Hultin LE; Cheng HL; Mitsuyasu RT; Detels R J Immunol; 1987 Jun; 138(11):3725-30. PubMed ID: 3108371 [TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of CD4-4B4 and CD4-2H4 lymphocyte subpopulations in HIV negative homosexual, HIV seropositive and healthy subjects. Vuillier F; Lapresle C; Dighiero G Clin Exp Immunol; 1988 Jan; 71(1):8-12. PubMed ID: 2964959 [TBL] [Abstract][Full Text] [Related]
3. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767 [TBL] [Abstract][Full Text] [Related]
4. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. Miedema F; Petit AJ; Terpstra FG; Schattenkerk JK; de Wolf F; Al BJ; Roos M; Lange JM; Danner SA; Goudsmit J J Clin Invest; 1988 Dec; 82(6):1908-14. PubMed ID: 2974045 [TBL] [Abstract][Full Text] [Related]
5. Immunologic abnormalities related to antigenaemia during HIV-1 infection. De Paoli P; Battistin S; Crovatto M; Modolo ML; Carbone A; Tirelli U; Santini G Clin Exp Immunol; 1988 Dec; 74(3):317-20. PubMed ID: 2976619 [TBL] [Abstract][Full Text] [Related]
6. CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. Lange CG; Valdez H; Medvik K; Asaad R; Lederman MM Clin Immunol; 2002 Feb; 102(2):154-61. PubMed ID: 11846457 [TBL] [Abstract][Full Text] [Related]
7. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. Martínez-Maza O; Crabb E; Mitsuyasu RT; Fahey JL; Giorgi JV J Immunol; 1987 Jun; 138(11):3720-4. PubMed ID: 2953790 [TBL] [Abstract][Full Text] [Related]
8. Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsets. Andrieu JM; Eme D; Venet A; Audroin C; Tourani JM; Stern M; Israel-Biet D; Beldjord K; Driss F; Even P Clin Exp Immunol; 1988 Jul; 73(1):1-5. PubMed ID: 3262463 [TBL] [Abstract][Full Text] [Related]
9. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836 [TBL] [Abstract][Full Text] [Related]
10. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945 [TBL] [Abstract][Full Text] [Related]
11. CD3+, CD56+ non-MHC restricted cytotoxic T lymphocytes in two fraternal AIDS patients: a case report. Warzynski MJ; Barbour SD; Winkler-Pickett RT; Ortaldo JR Cytometry; 1994 Dec; 18(4):231-6. PubMed ID: 7534677 [TBL] [Abstract][Full Text] [Related]
12. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution. Blankson JN; Gallant JE; Siliciano RF J Infect Dis; 2001 Feb; 183(4):657-61. PubMed ID: 11170994 [TBL] [Abstract][Full Text] [Related]
13. Mucosal immune dysfunction in AIDS pathogenesis. Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779 [TBL] [Abstract][Full Text] [Related]
14. LFA1 expression in HIV infection. Amiel C; Béné MC; May T; Canton P; Faure GC AIDS; 1988 Jun; 2(3):211-4. PubMed ID: 3134916 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the systemic immune response in HIV-1-infected patients suffering from opportunistic Candida infection. Punzón C; Resino S; Bellón JM; Muñoz-Fernández MA; Fresno M Eur Cytokine Netw; 2002; 13(2):215-23. PubMed ID: 12101077 [TBL] [Abstract][Full Text] [Related]
16. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1. Imlach S; McBreen S; Shirafuji T; Leen C; Bell JE; Simmonds P J Virol; 2001 Dec; 75(23):11555-64. PubMed ID: 11689637 [TBL] [Abstract][Full Text] [Related]
17. Relationship of antibodies against CD4+ T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion. Müller C; Kukel S; Bauer R Immunology; 1993 Jun; 79(2):248-54. PubMed ID: 8102120 [TBL] [Abstract][Full Text] [Related]
18. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. Fan J; Bass HZ; Fahey JL J Immunol; 1993 Nov; 151(9):5031-40. PubMed ID: 8409454 [TBL] [Abstract][Full Text] [Related]
19. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977 [TBL] [Abstract][Full Text] [Related]
20. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration]. Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]